People
The four wildfires in Southern California are affecting tens of thousands of people.
With headquarters located in San Diego, Calif. and Kalamazoo, Mich., Cirius Therapeutics is a clinical-stage pharmaceutical company focused on developing a treatment for NASH.
CARMA Therapeutics is based on technology from the Center for Cellular Immunotherapies at the University of Pennsylvania, and was spun out of the laboratory of Saar Gill, assistant professor of Hematology Oncology in the Perelman School of Medicine there.
Cox takes over for Vital Therapies CEO Terry Winters who will step down from the Vital Therapies Board and become a consultant to the company.
Experienced food industry executive Neil Davidson has been appointed as non-executive Chairman of OptiBiotix.
Five researchers were touted for their work in life sciences.
Goldfinch Bio continues to expand its leadership team.
The addition of Pellini means the San Diego-based firm launched earlier this year can increase its investing pace and tap his healthcare experience as an executive at Foundation.
BlueRock Therapeutics, which has locations in Toronto, NYC and Cambridge, Mass., rocketed to existence in December 2016 with $225M in venture funding to focus on regenerative medicine, using iPSC therapies.
Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years.
PRESS RELEASES